Absence of IgD-CD27+ memory B cell population in X-linked hyper-IgM syndrome

Journal of Clinical Investigation

Volumn 102, Issue 4, 1998, Pages 853-860

  Agematsu, Kazunaga ^a   Nagumo, Haruo ^a   Shinozaki, Koji ^a   Hokibara, Sho ^a   Yasui, Kozo ^a   Terada, Kihei ^b   Kawamura, Naohisa ^c   Toba, Tsuvoshi ^d   Nonoyama, Shigeaki ^e   Ochs, Hans D ^f   Komiyama, Atsushi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c OSAKA ROSAI HOSPITAL   (Japan)

^d CHIBA CHILDREN'S HOSPITAL   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CD27; CD40; CD70; Hyper IgM syndrome; Memory B cells

Indexed keywords

CD27 ANTIGEN; CD40 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HYPERIMMUNOGLOBULINEMIA; IMMUNOGLOBULIN PRODUCTION; MALE; MEMORY CELL; PRIORITY JOURNAL;

EID: 0032528846     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3409     Document Type: Article

References (44)

1. Rosen, F.S., S.V. Kevy, E. Merler, C.A. Janeway, and D. Gitlin. 1961. Recurrent bacterial infections and dysgamma-globulinemia: deficiency of 7S γ-globulins in the presence of elevated 19S γ-globulins. Pediatrics. 28:182-195.
2. Callard, R.E., R.J. Armitage, W.C. Fanslow, and M.K. Spriggs. 1993. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today. 14:559-564.
3. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
4. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 259:990-993.
5. DiSanto, J.P., J.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 361:541-543.
6. Armitage, R.J., W.C. Fanslow, L. Strockbine, T.A. Sato, K.N. Clifford, B.M. Macduff, D.M. Anderson, S.D. Gimpel, T. Davis-Smith, C.R. Maliszewski, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature. 357:80-82.
7. Stamenkovic, I., E.A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO (Eur. Mol. Biol. Organ.) J. 8:1403-1410.
8. Banchereau, J., and F. Rousset. 1991. Growing human B lymphocytes in the CD40 system. Nature. 353:678-679.
9. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldscmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
10. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 378: 620-623.
11. Chu, Y.W., E. Marin, R. Fuleihan, N. Ramesh, F.S. Rosen, R.S. Geha, and R.A. Insel. 1995. Somatic mutation of human immunoglohulin V genes in the X-linked hyper IgM syndrome. J. Clin. Invest. 95:1389-1393.
12. Han, S., K. Hathcock, B. Zheng, T.B. Kepler, R. Modes, and G. Kelsoe. 1995. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155:556-567.
13. Gray, D., P. Dullforce, and S. Jainandunsing. 1994. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction. J. Exp. Med. 180:141-155.
14. Arpin, C., J. Dechanet, C. Van Kooten, P. Merville, G. Grouard, F. Briere, J. Banchereau, and Y.J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science. 268:720-722.
15. Nonoyama, S., M.L. Farrington, and H.D. Ochs. 1994. Effect of IL-2 on immunoglobulin production by anti-CD40-activated human B cells: synergistic effect with IL-10 and antagonistic effect with IL-4. Clin. Immunol. Immunopathol. 72:373-379.
16. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D.H. Hsu, R. Kastelein, K.W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA. 89:1890-1893.
17. + T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 147:8-13.
18. Camerini, D., G. Walzz W.A.M. Lenen, J. Borst, and B. Seed. 1991. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 147:3165-3169.
19. Goodwin, R.G., M.R. Alderson, C.A. Smith, R.J. Armitage, T. Vanden-Bos, R. Jerzy, T.W. Tough, M.A. Schoenborn, T. Davis-Smith, K. Hennen, et al. 1993. Molecular and biochemical characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell. 73: 447-456.
20. Agematsu, K., T. Kobata, K. Sugita, T. Hirose, S.F. Schlossman, and C. Morimoto. 1995. Direct cellular communication between CD45RO and CD45RA T cell subset via CD27/CD70. J. Immunol. 154:3627-3635.
21. - CD70 interactions regulate B cell activation by T cells. Proc. Natl. Acad. Sci. USA. 92:11249-11253.
22. Agematsu, K., T. Kobata, F.C. Yang, T. Nakazawa, K. Fukushima, M. Kitahara, T. Mori, K. Sugita, C. Morimoto, and A. Komiyama. 1995. CD27/ CD70 interaction directly drives B cell IgG and IgM synthesis. Eur. J. Immunol. 25:2825-2829.
23. + B cells and helper T cells in immunoglobulin production. Eur. J. Immunol. 27:2073-2079.
24. Agematsu, K., H. Nagumo, Y. Oguchi, T. Nakazawa, K. Fukushima, K. Yasui, S. Ito, T. Kobata. C. Morimoto, and A. Komiyama. 1998. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of IL-10 and CD27/CD70 interaction. Blood. 91:173-180.
25. Jacquot, S., T. Kobata, S. Iwata, C. Morimoto, and S.F. Schlossman. 1997. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J. Immunol. 159:2652-2657.
26. Nonoyama, S., M. Shimazu, H. Toru, K. Seyama, H. Nunoi, M. Neubauer, J. Yata, and H.D. Ochs. 1997. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum. Genet. 99:624-627.
27. + CD4 T cell clones and involved in distinct immunoregulatory functions. J. Immunol. 149:3208-3216.
28. Morimoto, C. N.L. Letvin, J.A. Distaso, W.R. Aldrich, and S.F. Schlossman. 1985. The isolation of characterization of the human suppressor inducer T cell subset. J. Immunol. 134:1508-1515.
29. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
30. Gussow, D., R. Rein, I. Ginjaar, F. Hochstenbach, G. Seema, A. Kottman, and H.L. Ploegh. 1987. The human β2-microglobulin gene: primary structure and definition of the transcription unit. J. Immunol. 139:3132-3138.
31. Korthauer, U., D. Graf, H.W. Mages, F. Briere, M. Padayachee, S. Malcom, A.G. Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 361:539-541.
32. Saiki, O., T. Tanaka, Y. Wada, H. Uda, A. Inoue, Y. Katada, M. Izeki, M. Iwata, H. Nunoi, I. Matsuda, N. Kinoshita, and T. Kishimoto. 1995. Signaling through CD40 rescues IgE but not IgG and IgA secretion in X-linked immunodeficiency with hyper-IgM. J. Clin. Invest. 95:510-514.
33. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Roussel, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
34. Noelle, R.J. 1995. The role of gp39 (CD40L) in immunity. Clin. Immunol. Immunopathol. 76:203-207.
35. Durandy, A., C. Schiff, J.Y. Bonnefoy, M. Forveille, F. Roussel, G. Mazzei, M. Milili, and A. Fischer. 1993. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA, and IgE production by B cells from patients with X-linked hyper IgM syndrome. Eur. J. Immunol. 23:2294-2299.
36. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, R.S. Rosen, T. Chatila, S.M. Fu, I. Stamenkovic, and R.S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:2170-2173.
37. Foy, T.M., F.H. Durie, and R.J. Noelle. 1994. The expansive role of CD40 and its ligand, gp39, in immunity. Semin. Immunol. 6:259-266.
38. Durandy, A., C. Hivroz, F. Mazerolles, C. Schiff, F. Bernard, E. Jouanguy, P. Revy, J.P. DiSanto, J.F. Gauchat, J.Y. Bonnefoy, J.L. Casanova, and A. Fischer. 1997. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. J. Immunol. 158:2576-2584.
39. Durandy, A., C. Schiff, J.Y. Bonnefoy, M. Forveille, F. Roussel, G. Mazzei, M. Milili, and A. Fischer. 1993. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome. Eur. J. Immunol. 23:2294-2299.
40. Callard, R.E., S.H. Smith, J. Herbert, G. Morgan, M. Padayachee, S. Lederman, L. Chess, R.A. Kroczek, W.C. Fanslow, and R.J. Armitage. 1994. CD40 ligand (CD40L) expression and B cell function in a gammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers. J. Immunol. 153:3295-3306.
41. Splawski, J.D., D.F. Jelinek, and P.E. Lipsky. 1991. Delineation of the functional capacity of human neonatal lymphocytes. J. Clin. Invest. 87:545-553.
42. Nonoyama, S., L.A. Penix, C.P. Edwards, D.B. Lewis, S. Ito, A. Aruffo, C.B. Wilson, and H.D. Ochs. 1995. Diminished expression of CD40 ligand by activated neonatal T cells. J. Clin. Invest. 95:66-75.
43. Fuleihan, R., D. Ahern, and R.S. Geha. 1994. Decreased expression of the ligand for CD40 in newborn lymphocytes. Eur. J. Immunol. 24:1925-1928.
44. Splawski, J.B., J. Nishioka, Y. Nishioka, and P.E. Lipsky. 1996. CD40 ligand is expressed and functional on activated neonatal T cells. J. Immunol. 156:119-127.